Ocugen, Inc.
OCGN
$1.17
$0.010.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.75M | 1.37M | 1.48M | 764.00K | 1.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.75M | 1.37M | 1.48M | 764.00K | 1.14M |
| Cost of Revenue | 11.15M | 8.40M | 786.00K | 8.29M | 8.11M |
| Gross Profit | -9.40M | -7.03M | 695.00K | -7.53M | -6.97M |
| SG&A Expenses | 8.23M | 6.77M | 6.45M | 6.31M | 6.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.32M | -- | -- | -- | -1.00K |
| Total Operating Expenses | 20.70M | 15.17M | 15.98M | 14.60M | 14.39M |
| Operating Income | -18.94M | -13.80M | -14.50M | -13.84M | -13.25M |
| Income Before Tax | -20.05M | -14.74M | -15.35M | -13.88M | -12.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.05M | -14.74M | -15.35M | -13.88M | -12.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.05M | -14.74M | -15.35M | -13.88M | -12.97M |
| EBIT | -18.94M | -13.80M | -14.50M | -13.84M | -13.25M |
| EBITDA | -17.99M | -12.87M | -13.59M | -13.24M | -12.64M |
| EPS Basic | -0.07 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 |
| EPS Diluted | -0.07 | -0.05 | -0.05 | -0.05 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 |
| Average Basic Shares Outstanding | 304.00M | 292.07M | 292.00M | 290.92M | 278.17M |
| Average Diluted Shares Outstanding | 304.00M | 292.07M | 292.00M | 290.92M | 278.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |